Aberdeen Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,422,201
| Closed | -$20.6M | – | 938 |
|
|
2022
Q2 | $20.6M | Sell |
1,422,201
-20,383
| -1% | -$295K | 0.06% | 278 |
|
|
2022
Q1 | $37.7M | Buy |
1,442,584
+345,137
| +31% | +$9.02M | 0.1% | 219 |
|
|
2021
Q4 | $43.5M | Buy |
1,097,447
+100,829
| +10% | +$3.99M | 0.1% | 213 |
|
|
2021
Q3 | $49.8M | Buy |
996,618
+992,372
| +23,372% | +$49.6M | 0.11% | 190 |
|
|
2021
Q2 | $236K | Buy |
+4,246
| New | +$236K | ﹤0.01% | 992 |
|
|
2020
Q2 | – | Sell |
-23,060
| Closed | -$603K | – | 933 |
|
|
2020
Q1 | $603K | Buy |
+23,060
| New | +$603K | ﹤0.01% | 818 |
|